Coreline Soft AVIEW 2.0 uses unified GenAI automation to accelerate thoracic imaging and raise diagnostic precision.

Coreline Soft has introduced AVIEW 2.0, a next-generation GenAI powered radiology platform designed to unify chest imaging workflows. The company positions the system as a shift from narrow AI tools to a fully integrated diagnostic engine, using generative automation to tackle one of radiology’s persistent challenges. Basically it is the fragmented analysis across lung, cardiac, and airway diseases. AVIEW 2.0 merges lung-cancer screening, coronary calcium scoring, and COPD quantification into a continuous pipeline. Altogether, this reduces interpretation time by 60% and enabling case throughput to improve by 89%.

as can be seen this integrated approach addresses the complexity of multi-disease CT assessment. Traditional workflows require radiologists to juggle several software tools, each with separate data streams and quality thresholds. AVIEW 2.0 uses generative modeling to harmonize these tasks. As well as reconstruct missing features, standardize image patterns, and surface annotated insights that span multiple organ systems. The platform has been validated through 2.5 million scans across 19 countries. Providing a uniquely diverse dataset that strengthens model robustness and reduces bias.

European nations have adopted AVIEW as national lung-screening infrastructure. This reflects a shift toward treating GenAI as a clinical requirement rather than a pilot technology. The platform’s generative reasoning supports structured reporting, automated triage, and deep quantification at a population scale. In the U.S., centers including UMass Memorial Medical Center and Temple Lung Center use AVIEW to manage full-spectrum thoracic screening. These deployments highlight the model’s adaptability to real hospital workflows. Where generative outputs must align with site-specific protocols and regulatory standards.

Coreline Soft will demonstrate an end-to-end AI workflow at RSNA 2025, showing how AVIEW and its HUB system integrate triage. As well as interpretation, reporting, and quality controls. The company positions AVIEW 2.0 as essential radiology infrastructure. This aims to raise consistency, reduce diagnostic load, and deliver scalable precision medicine.